Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic LeukemiaStuart E. Siegel, Archie Bleyer, Selina M. Luger et al.|JAMA Oncology|2018Cited by 168
Preliminary Evidence Of Anti Tumor Activity Of Selinexor (KPT-330) In a Phase I Trial Ofa First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) In Patients (pts) With Relapsed / Refractory Non Hodgkin’s Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)John Kuruvilla, Mansoor Raza Mirza, Martin Gutierrez et al.|Blood|2013Cited by 30
Frontline treatment of adults with newly diagnosed B-cell acute lymphoblastic leukaemiaIbrahim Aldoss, Elias Jabbour, Gail J. Roboz et al.|The Lancet Haematology|2024Cited by 4
Obecabtagene autoleucel (obe-cel) for Adult Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL): Deep Molecular Remission May Predict Better OutcomesElias Jabbour, Claire Roddie, Jae H. Park et al.|Blood|2024Cited by 3
Deep Molecular Remission Predicts Better Clinical Outcomes in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) Treated with Obecabtagene Autoleucel (obe-cel)Elias Jabbour, Claire Roddie, Jae H. Park et al.|Transplantation and Cellular Therapy|2025Cited by 2